Anthrax DNA vaccine - Fresh Tracks Therapeutics/Ohio State University
Latest Information Update: 22 Sep 2023
Price :
$50 *
At a glance
- Originator Ohio State University; Vical
- Developer Fresh Tracks Therapeutics
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anthrax
Most Recent Events
- 19 Sep 2023 Discontinued - Phase-I for Anthrax in USA (unspecified route)
- 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
- 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary